Sun Wan-Jun, Xu Dong-Gang, Hu Hai-Lan, Zou Min-Ji, DU Jian-Fang, Wang Jin-Feng, Cai Xin, Wang Jia-Xi, Ai Hui-Sheng
Department of Hematology, Affiliated Hospital, Academy of Military Medical Sciences, Beijing 100071, China.
Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2007 Apr;15(2):352-6.
This study was aimed to construct the soluble HLA-A0201-PR1 complex for preparation of HLA-A0201-PR1 tetramer. The recombinant HLA-A0201-BSP (BirA substrate peptide) fusion protein as heavy chain and beta(2)-microglobulin (beta(2) m) as light chain were expressed highly as insoluble aggregates in Escherichia coli and then purified with gel filtration, and the final purity reached above 90%. The two subunits were refolded to form an HLA-A0201-peptide complex by dilution method in the presence of an antigenic peptide PR1, a HLA-A2-restricted peptide from proteinase 3 (aa 169 - 177, VLQELNVTV). Refolded HLA-A0201-PR1 complex was biotinylated using a BirA enzyme and purified by anion exchange chromatography on a Q-Sepharose (fast flow) column. The extent of reconstitution of the HLA-A0201-PR1 complex was analyzed by HPLC gel filtration. The refolded and biotinylated products were detected by Western blot and ELISA with monoclonal antibody BB7.2 that recognized the natural conformations of HLA-A2 and streptavidin. The results showed that the refolded complex was composed of HLA-A0201-BSP aggregate, HLA-A0201-PR1 complex and beta(2) m, and reconstitution yields of 18% with PR1 was obtained. Refolded HLA-A0201-PR1 complex could be confirmed by practical immunological method and biotinylated efficiently. It is concluded that the refolding and biotinylation of HLA-A0201-PR1 complex is successfully obtained. This work provides the basis for the preparation of HLA-A*0201-PR1 tetramer.
本研究旨在构建可溶性HLA-A0201-PR1复合物,用于制备HLA-A0201-PR1四聚体。作为重链的重组HLA-A0201-BSP(BirA底物肽)融合蛋白和作为轻链的β2-微球蛋白(β2m)在大肠杆菌中以不溶性聚集体的形式高效表达,然后通过凝胶过滤进行纯化,最终纯度达到90%以上。在抗原肽PR1(一种来自蛋白酶3的HLA-A2限制性肽,aa 169 - 177,VLQELNVTV)存在的情况下,通过稀释法将两个亚基重折叠以形成HLA-A0201-肽复合物。重折叠的HLA-A0201-PR1复合物用BirA酶进行生物素化,并在Q-Sepharose(快速流动)柱上通过阴离子交换色谱法进行纯化。通过HPLC凝胶过滤分析HLA-A0201-PR1复合物的重构程度。用识别HLA-A2天然构象的单克隆抗体BB7.2和链霉亲和素通过蛋白质印迹法和ELISA检测重折叠和生物素化的产物。结果表明,重折叠的复合物由HLA-A0201-BSP聚集体、HLA-A0201-PR1复合物和β2m组成,与PR1的重构产率为18%。重折叠的HLA-A0201-PR1复合物可以通过实际免疫学方法得到证实,并能有效地进行生物素化。结论是成功获得了HLA-A0201-PR1复合物的重折叠和生物素化。这项工作为制备HLA-A*0201-PR1四聚体提供了基础。